Physician profile
Andrew N Rassi
NPI 1609042753
$24,462.87
in general payments reported to CMS, 2019-2025
8 companies · $6,312 in 2025
The $6,312 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2022: $2,037 · 2023: $7,687 · 2024: $8,278 · 2025: $6,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Consulting Fee: $4,000 · Food and Beverage: $3,989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,287.92 |
| Consulting Fee | $4,000.00 |
| Food and Beverage | $3,988.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,437.43 | 2022-2025 | Apollotm, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $6,709.59 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $4,874.35 | 2022-2023 | |
| Abbott Laboratories | $2,135.54 | 2019-2024 | Diamondback Coronary |
| Abiomed | $173.17 | 2024 | Impella |
| Shockwave Medical, INC | $76.05 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $56.74 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Rassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.